Method and system for sensing respiration of subject and use of method and system in treatment of obstructive sleep apnea
By measuring and analyzing the acoustic and motor signals during electrical nerve stimulation, the accuracy and invasiveness of monitoring the treatment effect of obstructive sleep apnea in the prior art is solved, and the accurate treatment effect for patients with obstructive sleep apnea is achieved. Monitor and optimize.
Patent Information
- Application Number
- CN202380026758.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-11
- Filing Date
- 2023-03-03
- Publication Date
- 2024-11-15
AI Technical Summary
The prior art has defects in monitoring and quantifying the therapeutic effect of neuromodulation therapy on obstructive sleep apnea, especially the method of sensing breathing is not accurate and seamless enough, and is highly invasive, affecting the assessment of the degree of treatment coverage.
By measuring the acoustic and motion signals during electrical nerve stimulation, assigning indicator hit rate and inspiratory air flow values to determine stimulation synchronization during breathing mode and blocking event periods, using an acoustic and motion sensing unit combined with a signal processing algorithm, Optimize the timing and parameter adjustment of stimulation sequences to achieve more accurate monitoring of treatment effects.
A simple and accurate method is provided to monitor the therapeutic effects of patients with obstructive sleep apnea, especially the efficacy of sublingual nerve stimulation, which can optimize monitoring and adjustment of stimulation sessions and improve the accuracy and long-term effectiveness of treatment.
Smart Images

Figure CN118973477A_ABST
Abstract
Description
Technical Field
[0001] The invention described herein relates to methods for sensing the respiration of a subject, systems for implementing the methods, and the use of the methods and systems in the treatment of obstructive sleep apnea. Background Art
[0002] Neuromodulation, i.e. electrical stimulation of nerves, is well known in the prior art as a reliable and effective type of medical treatment. It provides the opportunity to treat many physiological conditions and disorders by interacting with the body's own natural neural processes. Neuromodulation includes inhibition (e.g. blocking), stimulation, modification, regulation or therapeutic changes of electrical or chemical activity in the central, peripheral or autonomic nervous system. By modulating the activity of the nervous system, several different goals can be achieved. For example, motor neurons can be stimulated at the appropriate time to cause muscle contraction. In addition, sensory neurons can be blocked to relieve pain or stimulated to provide signals to subjects (i.e. people with sleep apnea). In other examples, modulation of the autonomic nervous system can be used to adjust various involuntary physiological parameters, such as heart rate and blood pressure. Neuromodulation can provide the opportunity to treat several diseases or physiological conditions. Various devices and techniques have been used to try to provide optimal stimulation to the tissue of interest.
[0003] Within the content of the present disclosure, the expressions "nerve stimulation", "neural stimulation", "nerve modulation" and "neural modulation" are used synonymously, unless it is obvious from the corresponding context. Generally, the above expressions refer to the process of generating an electric field near a nerve or a group of nerves to cause one or more muscles associated with the nerves to contract. Likewise, the expressions "subject" and "patient" are used synonymously, unless it is obvious from the corresponding context. Both terms refer to a person who may suffer from OSA.
[0004] One of the conditions to which neuromodulation can be applied is obstructive sleep apnea (OSA), a breathing disorder characterized by recurrent episodes of partial or complete obstruction of the upper airway during sleep. One of the main causes of OSA is that the tongue muscles cannot resist the negative inspiratory pressure in the pharynx due to sleep-related loss of muscle tone. When the tongue is pulled back, it blocks the upper airway, reducing ventilation and lowering lung and blood oxygen levels. Stimulation of the hypoglossal nerve ("Hypoglossal Nerve Stimulation" or HGNS) causes the tongue muscles to contract, thereby maintaining an open, unobstructed airway. When a person without OSA sleeps, the pharyngeal muscles (a group of muscles that form the pharynx) relax and gradually collapse, narrowing the airway. The narrowed airway in turn limits the effectiveness of the sleeper's breathing, resulting in elevated CO2 levels in the sleeper's blood. The increase in CO2 causes the pharyngeal muscles to contract to open the airway to restore proper breathing. The largest of the pharyngeal muscles responsible for upper airway dilation is the genioglossus, one of several different muscles in the tongue.
[0005] The genioglossus muscle is responsible for the forward movement of the tongue and the stiffening of the anterior pharyngeal wall. In patients with OSA, the neuromuscular activity of the genioglossus muscle is reduced compared to normal individuals, which explains the insufficient reaction and contraction of patients with OSA to open the airway compared to normal individuals. The lack of this reaction leads to partial or complete airway obstruction, which significantly limits the effectiveness of the sleeper's breathing. In OSA patients, there are usually several airway obstruction events at night. Due to the obstruction, the O2 level in the blood gradually decreases (hypoxemia). Hypoxemia causes night awakening, which can be recorded by EEG, indicating that the brain wakes up from any stage of sleep to a brief awakening. During the awakening, there is conscious breathing or gasping, which solves the airway obstruction. Increasing the sympathetic tone activity rate by releasing hormones such as adrenaline and norepinephrine also often occurs as a response to hypoxemia. Due to the increase in sympathetic tone, the heart enlarges in an attempt to pump more blood and increase blood pressure and heart rate, further awakening the patient after the apnea event subsides, and when the patient resumes sleep, the airway collapses again, causing further awakening.
[0006] In order to quantify the efficacy of neuromodulation as a treatment method (particularly HGN) and for analytical purposes, it is important to closely monitor the treatment response. This is typically achieved by monitoring the subject's chest movement and nasal and / or oral airflow, for example using a PSG (sleep study or polysomnography) or a CPAP (Continuous Positive Airway Pressure) mask.
[0007] The above methods have several disadvantages. Solutions involving airflow are not suitable for seamless implementation in existing systems for neurostimulation. Furthermore, the use of masks and the like may be considered annoying by the subject. As for self-assessment or visualization of airway opening or tongue protrusion, these methods may be highly subjective and therefore subject to variable results or errors. Furthermore, even objective visual assessments only provide qualitative results rather than quantitative results.
[0008] Other concepts for monitoring the therapeutic efficacy of neurostimulation focus on breathing detection. Here, implanted intracostal breathing sensing leads are used to monitor the patient's breathing pattern. However, this method is invasive because implanting an electronic system that is not located in the area of the stimulation implant requires a longer or even additional surgery.
[0009] The objective technical problem of the present disclosure is to eliminate the disadvantages of the prior art and provide a method for sensing the respiration of a subject in order to determine the degree of treatment coverage relative to the desired treatment period in order to quantify the efficacy of the neuromodulation therapy. In addition, the method should improve the electrical stimulation of nerves in patients with OSA. Summary of the invention
[0010] The main features of the method according to the present disclosure are specified by claim 1. Specific embodiments or advantageous variants of the method are described in claims 2 to 9. Claims 10 to 11 specify a system for implementing the method. Furthermore, claim 12 specifies the use of the method.
[0011] According to a first aspect of the present disclosure, an objective technical problem is solved by a method for sensing the breathing of a subject in response to electrical neural stimulation, the method comprising:
[0012] - measuring acoustic and / or motor signals induced by the subject's breathing during an electrical nerve stimulation session;
[0013] - assigning to the measured acoustic signal and / or the measured motion signal a value indicative of the hit rate and / or the inspiratory airflow (ie inspiration and / or obstruction events).
[0014] Hit rate and / or inspiratory airflow values allow for determination of breathing patterns and synchronization of stimulation with respect to desired periods of inhalation and / or occlusive events of the subject.
[0015] Preferably, the acoustic signal is measured using at least one acoustic sensing unit, wherein the acoustic sensing unit may in particular comprise at least one microphone. The acoustic sensing unit or the microphone may for example be located outside the subject's body. According to a preferred embodiment, the at least one sensing unit may be configured under the subject's chin.
[0016] The acoustic signal may include any noise emitted by the subject. However, the acoustic signal may preferably be the sound of the subject's breathing or snoring. The acoustic sensing unit or microphone may be configured to capture even slight breathing sounds of the subject while sleeping. Furthermore, a proprietary signal processing algorithm may be implemented, with which the inhalation phase and the exhalation phase of the subject over time may be detected.
[0017] The motion signal may include any motion generated by the subject's movement and sensed by the motion sensing unit. However, the motion signal may preferably be an airway muscle or jaw displacement caused by the subject's breathing. The motion sensing unit may include an inertial measurement unit (IMU) and / or a gyroscope and may be configured to capture even slight breathing movements of the subject while sleeping. In addition, a proprietary signal processing algorithm may be implemented, with which the subject's inhalation phase and exhalation phase over time may be detected.
[0018] Using the above method, the breathing pattern of the subject can be reliably measured and / or monitored and based thereon the stimulation level synchronized with the subject's inhalation phase can be quantified (so-called hit rate quantification). The timing of the start of the stimulation sequence can also be optimized within the subject's breathing cycle.
[0019] According to an advantageous embodiment, the method may further comprise: generating a modulation signal comprising an electrical stimulation pattern; applying the modulation signal to at least one pair of electrodes associated with an implant unit implanted in a subject; adjusting at least one parameter of the electrical stimulation pattern in response to a value indicative of a hit rate and / or an inspiratory airflow, i.e. in response to the measured acoustic / motion signal. In this way, the monitoring of the efficacy of the stimulation session may be even further optimized, since two separate effects of the stimulation are monitored independently, allowing a clearer picture.
[0020] Using the above method, the efficacy of neurostimulation during treatment of patients with OSA, in particular the efficacy of stimulation of the hypoglossal nerve or the cervical loop, can be monitored in a simple and accurate manner. It should be understood that the hypoglossal nerve innervates the genioglossus muscle, and the cervical loop innervates the infrahyoid strap muscle, which is responsible for stiffening or collapsing the subject's upper airway. The infrahyoid muscles include the sternohyoid muscle, the sternothyroid muscle, the omohyoid muscle, and the thyrohyoid muscle. In addition, if necessary, the system allows continuous monitoring over a desired period of time, thereby providing important information about the long-term effects of neurostimulation treatment.
[0021] In the sense of the present disclosure, muscle contraction may refer to muscle displacement, and unless otherwise specified, these expressions are used synonymously. Muscle contraction may particularly refer to (but not limited to) displacement of the subject's tongue or other muscles associated with the subject's airway.
[0022] In the sense of the present disclosure, movement of one or more muscles associated with the airway of a subject may also include movement of the subject's jaw, since displacement of one or more muscles involved in the patient's airway during breathing will also result in jaw movement. Thus, monitoring of a patient's breathing, e.g. based on acoustic signals and / or muscle displacements, may also be determined by measuring jaw movement of the subject and the subject's breathing sounds in the jaw region.
[0023] The modulated signal comprising the electrical stimulation pattern is preferably generated by an external device that can be configured to be placed under the chin of the subject. In particular, the modulated signal can be generated by a control unit and / or a processor, both of which can be part of the external unit. The modulated signal can also be transmitted to the implanted unit using a transmitting element, which can include an antenna or a coil associated with the control unit.
[0024] According to another embodiment, instead of or in addition to the control unit of the external device, the control unit may be part of an implanted unit implanted beneath the skin of the subject. In this way, the control unit may be located directly on the muscle to be monitored, for example, on the genioglossus or on one or more of the infrahyoid muscles, in particular the sternohyoid or sternothyroid muscles. In other words, the location of the control unit is not essential for the basic method of the present disclosure. Either way, the control unit may preferably be in electrical communication with the at least one motion sensing unit.
[0025] The step of applying the modulated signal to at least one pair of electrodes may preferably be accomplished by an implant unit. The implant unit may be implanted near or around any muscle associated with the airway of the subject (e.g., the genioglossus muscle, which is innervated by the hypoglossal nerve). The implant unit may include circuitry that receives the electrical stimulation pattern via electrical communication between an external device and the implant unit, and in turn generates an electric field via at least one pair of electrodes associated with the implant unit.
[0026] The step of determining the movement of one or more muscles associated with the subject's tongue in response to the modulated signal may preferably be implemented by a motion sensing unit. The method may also be characterized in that at least one motion sensing unit includes at least one inertial measurement unit (IMU) and / or at least one strain gauge. According to an exemplary embodiment, the movement of one or more muscles associated with the subject's tongue may also be determined by detecting the movement of the subject's jaw, because the movement of the subject's tongue will also result in the movement of the subject's jaw.
[0027] Using the proposed method, as with known methods, the physiological effect achieved via the stimulation therapy, namely increasing the inspiratory airflow of the subject, can be monitored with greater accuracy.
[0028] Using the methods described herein, in addition to monitoring the breathing pattern of the subject, physiological conditions that are directly affected by the potential neural stimulation treatment, namely muscle contraction and therefore protrusion of the subject's tongue, can also be monitored. In this way, accurate information about the efficacy of the treatment can be obtained. Based on the degree of airway opening determined in response to stimulation with a defined set of stimulation parameters, those parameters can also be adjusted to improve the efficacy of the treatment. For example, if the set set of stimulation parameters is not sufficient to cause tongue protrusion and open the airway, the potential stimulation parameters can be adjusted accordingly, for example by increasing the stimulation intensity, or if the set set of stimulation parameters is not sufficient to cause the desired hit rate, the potential stimulation parameters can be adjusted accordingly, for example by adjusting the stimulation cycle length and distribution.
[0029] According to another embodiment of the method, time periods indicative of inhalation phases and occlusive events of the subject are detected and subsequently, stimulation levels synchronized with these time periods are quantified, for example based on acoustic signals and / or muscle displacements.
[0030] According to one embodiment disclosed herein, the method may further include the following steps: adjusting at least one parameter of the electrical stimulation pattern in response to a hit rate and / or an inspiratory airflow and / or in response to a determined time period indicating an inhalation phase and an upper airway obstruction event of the subject. In this way, a stimulation method based on feedback or a closed loop is provided, wherein the efficacy of an ongoing stimulation session is determined by measuring the subject's breathing sounds or displacement of airway muscles during inhalation (i.e., detecting inhalation phases and upper airway obstruction events), and then adjusting the stimulation parameters in response to the measured degree of synchronization of the stimulation with these events (i.e., an estimated hit rate). The detection of such a respiratory event may be determined, for example, by measuring only an acoustic signal, or by detecting the movement of muscles associated with inhalation in the airway, or by detecting the movement of the subject's jaw in addition to measuring an acoustic signal. The adjustment of at least one stimulation parameter may occur automatically or manually (e.g., by a doctor or by the subject himself) or both. In the case of automatic adjustment, at least one stimulation parameter may be changed after a set time delay or more or less immediately (i.e., in real time). This process may be automatically repeated in an iterative manner until the automatic adjustment of one of the stimulation parameters results in the determination of a value indicative of a desired degree of synchronization of the stimulation with the subject's inhalation and / or upper airway obstruction events.
[0031] In order to implement a feedback-based stimulation session or a closed-loop stimulation session, the control unit can be configured to perform logical operations such as comparing a determined hit rate (the determined hit rate is based on data corresponding to the breathing sounds of the subject determined by the acoustic sensing unit, or alternatively, based on data corresponding to the movement of one or more muscles associated with the subject's inhalation determined by the motion sensing unit) with a predetermined value and adjusting one or more of the stimulation parameters accordingly. For example, in the event that the hit rate determined based on the measured acoustic signal is lower than a predetermined value, the control unit can be configured to adjust the stimulation sequence length and interval.
[0032] Advantageously, the movement of muscles associated with the subject's airway may include muscle contraction, a change in tongue position and / or a change in the spatial orientation of the tongue within the subject, and / or movement of the subject's jaw. In particular, but not exclusively, muscle contraction may refer to contraction of the genioglossus muscle, particularly when innervated by the hypoglossal nerve. It is also possible to use at least one motion sensing unit to determine the movement of one or more muscles associated with the subject's tongue. The method may also be characterized in that at least one motion sensing unit includes at least one inertial measurement unit and / or at least one strain gauge. According to another embodiment, the inertial measurement unit may include at least one accelerometer and / or at least one gyroscope and / or at least one magnetometer. Preferably, at least one accelerometer may be implemented, wherein the accelerometer may include a single-axis accelerometer or a multi-axis accelerometer. In this way, the degree of airway opening and therefore the therapeutic efficacy may be determined with even higher accuracy, because two separate and independent stimulation effects (respiration and muscle contraction) may be monitored using the preferred method.
[0033] At least one parameter may include pulse train amplitude, pulse train length, single pulse frequency, single pulse duration, hold duration, pulse train interval, duty cycle, delay time, ramp duration, step-down amplitude, ramp duration at the start of a sequence, and / or confirmation pulse / sequence amplitude. The stimulation parameters may be adjusted automatically based on the values assigned to the measured hit rate and airway opening, or the parameters may be adjusted by the physician or the patient themselves upon receiving information that the current stimulation parameters are insufficient.
[0034] According to another aspect of the invention, a system for measuring the hit rate and / or the degree of inspiratory airflow, for example based on acoustic signals and / or muscle displacements exhibited by a subject, is proposed, the system comprising:
[0035] - an implant unit configured for implantation near or around any muscle associated with the airway of the subject (e.g., the genioglossus muscle), the implant unit comprising at least one pair of electrodes;
[0036] - an external device configured to communicate with the implanted unit;
[0037] - at least one acoustic sensing unit for sensing acoustic signals of the subject caused by the subject's breathing, and / or at least one motion sensing unit for sensing movements associated with the subject's breathing.
[0038] The system may preferably be configured to implement the methods described herein.
[0039] According to a preferred embodiment, the motion sensing unit is a microphone as part of the external device. In this way, since the external device is placed outside the subject in the vicinity of the implanted unit, i.e. under the chin of the subject, the acoustic sensing unit as part of the external device is automatically placed in a favorable position for detecting acoustic signals, such as breathing sounds of the subject.
[0040] In addition to the above, the system can include a motion sensing unit responsive to the modulated signal applied to the at least one pair of electrodes for determining movement of one or more muscles associated with the airway of the subject.
[0041] In addition, the system may include a control unit. The control unit may be part of an external device. In this case, the control unit may transmit a modulation signal or a stimulation input signal (e.g., a stimulation parameter) and power to the implanted unit. The control unit may also receive determined data corresponding to the breathing sounds of the subject determined by the acoustic sensing unit, or in addition, receive data corresponding to the movement of one or more muscles associated with the subject's airway determined by the motion sensing unit, and assign a value to the assigned airway opening degree. According to a preferred embodiment, the control unit is also capable of adjusting at least one of the stimulation parameters in response to a value indicating a hit rate and / or an inspiratory airflow.
[0042] Thus, the control unit may include one or more processors, which may include any circuit configured to perform a logical operation on at least one input variable. Thus, at least one processor of the control unit may include one or more integrated circuits, microchips, microcontrollers and microprocessors, which may be all or part of a central processing unit (CPU), a digital signal processor (DSP), a field programmable gate array (FPGA) or any other circuit known to those skilled in the art that may be suitable for executing instructions or performing logical operations.
[0043] The implant unit can be configured for implantation in a location that allows it to modulate a nerve (e.g., the hypoglossal nerve). The implant unit can be located within the subject such that there is intervening tissue between the implant unit and the nerve to be modulated. The intervening tissue can include muscle tissue, connective tissue, organ tissue, or any other type of biological tissue. Thus, the location of the implant unit does not need to be in immediate contact with the nerve for effective neuromodulation. The implant unit can also be positioned directly adjacent to the nerve such that there is no intervening tissue.
[0044] In treating OSA, the implant unit may be located on the genioglossus muscle of the patient or subject. Such a location is suitable for modulation of the hypoglossal nerve, whose branches run inside and innervate the genioglossus muscle. However, the implant unit may also be configured to be placed in other locations.
[0045] The external device may be configured to be positioned externally to the patient, in direct contact with the skin or close to the patient's skin. The external device may also be configured to be secured to the patient, for example, by adhering to the patient's skin or by a band or other device configured to hold the external device in place. Adherence to the skin of the external unit may occur so that it is near or around the location of the implanted unit. Preferably, the external device includes at least one acoustic sensing unit (e.g., a microphone).
[0046] The external device can be configured to be fixed to the patient. For example, the external device can be configured to be placed under the chin of the subject and / or the front of the patient's neck. The suitability of the placement position can be determined by communication between the external device and the implant unit. The external device can include a housing, wherein the housing can be any suitable container configured to store electrical components. In addition, the housing can be any suitable size and / or shape, and can be rigid or flexible. Examples of housings for external devices can include one or more of patches, buttons, or other containers having different shapes and sizes and made of any suitable material. The external device can be configured to adhere to a desired position. Therefore, in some embodiments, at least one side of the housing can include an adhesive material. The adhesive material can include a biocompatible material, and can allow the patient to adhere the external unit to a desired position and remove the external device when use is completed. The adhesive can be configured for single or multiple uses of the external unit. Suitable adhesive materials can include, but are not limited to, biocompatible glues, starches, elastomers, thermoplastics, and emulsions.
[0047] According to one embodiment, the at least one motion sensing unit may be part of the implanted unit and / or the at least one motion sensing unit may be part of the external device. The implanted unit and the external device may also include a motion sensing unit. If this is the case, the motion sensing units may be different from each other, i.e. the motion sensing unit of the internal unit may be a strain gauge and / or a gyroscope, and the motion sensing unit of the external device may be a gyroscope. For example, if the motion sensing unit is part of the external device, the motion sensing unit may preferably be an IMU configured to detect jaw movement, because the external device is preferably located under the chin of the subject, and because a stimulation event that causes contraction of one or more muscles associated with airway or tongue movement will also cause movement of the subject's jaw. If the motion sensing unit is part of the implanted unit, the motion sensing unit may preferably include a strain gauge, either as a separate component or together with an IMU, because the strain gauge is suitable for detecting and measuring muscle contractions, and the IMU is suitable for detecting movement of slight movements caused by respiratory phases and muscle collapse.
[0048] Thus, using the system described herein, at least one physiological effect of neural stimulation of one or more nerves responsible for controlling the muscles of the subject's airway (i.e., the subject's breathing sounds) can be monitored via the implementation of an acoustic sensing unit, and the degree of airway opening can be determined based on the measured acoustic signal. In addition, the system can be configured to automatically adjust at least one or more stimulation parameters to improve stimulation based on the degree of airway opening determined in this manner. For example, the described system can be used to quantify the stimulation level synchronized with the subject's inhalation phase (hit rate quantification).
[0049] Advantageously, the degree of airway openness can be determined based on detected movement of one or more muscles associated with the subject's airway in addition to being determined based on measured acoustic signals (eg, the subject's breathing sounds).
[0050] According to another aspect of the present disclosure, the use of the method disclosed herein for treating obstructive sleep apnea is proposed. The treatment of obstructive sleep apnea that can use this method can, for example, include the following steps:
[0051] - receiving the modulated signal at an implant unit implanted at an internal location on the underside of the subject's chin (e.g., near the genioglossus muscle);
[0052] - applying the modulated signal to at least one pair of electrodes associated with the implant unit to generate an electric field;
[0053] -and causing modulation of the subject's hypoglossal nerve or cervical loop in response to an electric field generated by at least one pair of electrodes, wherein modulation of the hypoglossal nerve can be limited to the medial branch of the hypoglossal nerve and can begin from a single modulation site along the medial branch.
[0054] Thus, at least one pair of modulating electrodes can be configured for implantation through the dermis on the underside of the subject's chin and for proximity to the location of the terminal fibers of the medial branch of the subject's hypoglossal nerve. Additionally, the implantable unit and the electrodes can be configured to cooperate to generate an electric field suitable for modulating one or more of the terminal fibers of the medial branch of the hypoglossal nerve.
[0055] Any one of the embodiments, examples, or features disclosed herein may be used in combination with any one of the aspects of the disclosed subject matter or alone. BRIEF DESCRIPTION OF THE DRAWINGS
[0056] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate several examples of the disclosed subject matter. The accompanying drawings show the following:
[0057] Figure 1 shows a schematic diagram of the system disclosed herein according to a first embodiment;
[0058] Figure 2 shows a schematic diagram of a system according to a second embodiment;
[0059] Figure 3 A schematic diagram of a system according to a third embodiment is shown. DETAILED DESCRIPTION
[0060] Figure 1 A schematic diagram of a system 100 for measuring hit rate and / or degree of inspiratory airflow, for example based on acoustic signals and / or muscle displacements caused by a subject's breathing, for example in response to electrical neural stimulation, wherein the acoustic signals may include breathing sounds of the subject, and wherein the muscles may include movement of one or more of the tongue, genioglossus, or infrahyoid stifle muscles. Figure 1 The flowchart of can be used as an example of implementation of the method. Figure 1 , the neurostimulation system 100 configured to implement the method includes a control unit 500 and an acoustic sensing unit 400. In addition, the system 100 may preferably include an implant unit 200 (not shown) and an external device 300 (not shown), the implant unit 200 being configured to be implanted around any muscle associated with the airway of the subject (e.g., the genioglossus muscle), and the external device 300 being configured to electrically communicate with the implant unit 200.
[0061] The implant unit 200 of the system 100 that can perform the method can be implanted near the genioglossus muscle innervated by the hypoglossal nerve, or implanted into one of the infrahyoid muscles innervated by the cervical loop. The implant unit 200 can also include a transmitting element and a circuit, and the transmitting element can include a secondary antenna or coil, and the circuit receives the electrical stimulation pattern through electrical communication between the external device 300 and the implant unit 200. Upon receiving the electrical stimulation pattern, the circuit can generate an electric field via at least one pair of electrodes associated with the implant unit 200. If the electric field is strong enough and / or close enough to the hypoglossal nerve, the nerve will be stimulated and innervate the genioglossus muscle, which in turn will contract. The specifications of the implant unit 200 are not limited to a specific embodiment, as long as the implant unit 200 is configured for use with the method described herein.
[0062] The external device 300 of the system 100 that can perform the method can be configured to be located outside the patient, particularly under the chin of the subject and / or the front of the patient's neck. Therefore, the external device 300 can be configured to be fixed to the patient, for example, by adhering to the patient's skin or by a band or other device configured to keep the external device in place. The external device 300 may preferably include a housing, wherein the housing may be any suitable container configured to store electrical components. In addition, the housing may be of any suitable size and / or shape and may be rigid or flexible. Examples of housings for the external device 300 may include one or more of patches, buttons, or other containers having different shapes and sizes and made of any suitable material. The specifications of the external device 300 are not limited to a specific embodiment, as long as the implant unit 200 is configured to be used with the method described herein.
[0063] To measure the acoustic signal caused by the subject (i.e., the breathing noise sound emitted by the subject), the system 100 includes an acoustic sensing unit 400, which may be a microphone. To measure the motion signal caused by the subject, the system 100 includes a motion sensing unit 600, which may be an inertial measurement unit, an accelerometer, at least one gyroscope, and / or at least one magnetometer.
[0064] Finally, according to Figure 1 The system 100 may include a control unit 500, for example as part of the external device 300. The control unit 500 may transmit modulation or stimulation input signals (eg, stimulation parameters) and power to the implant unit 200.
[0065] according to Figure 1In the method depicted in , the control unit 500 may also receive data corresponding to the acoustic signal measured by the acoustic sensing unit 400 or the motion signal measured by the motion sensing unit, and assign a value related to the hit rate and / or the inspiratory airflow to the acoustic signal or the motion signal. According to a preferred embodiment of the method, the control unit 500 is also capable of adjusting at least one of the stimulation parameters in response to the value indicating the hit rate and / or the inspiratory airflow. Therefore, the control unit 500 may include one or more processors, which may include any circuit configured to perform a logical operation on at least one input variable. At least one processor of the control unit 500 may, for example, include one or more integrated circuits, microchips, microcontrollers, and microprocessors, which may be all or part of a central processing unit (CPU), a digital signal processor (DSP), a field programmable gate array (FPGA), or any other circuit known to those skilled in the art that may be suitable for executing instructions or performing logical operations. In this way, a method for feedback-based or closed-loop neural stimulation is provided, in which the efficacy of an ongoing stimulation session is determined by measuring the degree of airway opening and then automatically adjusting the stimulation parameters in response to the measured degree of airway opening.
[0066] according to Figure 1 , the control unit 500 can be part of the external device 300, part of the implant unit 200, or part of both the external device 300 and the implant 200.
[0067] Figure 2 A schematic diagram of a system 100 for measuring hit rate and / or inspiratory airflow according to a second embodiment is shown, for example based on acoustic and / or motion signals induced by the breathing of a subject, for example in response to electrical neural stimulation. Figure 2 The system 100 shows the acoustic sensing unit 400 and / or the motion sensing unit 600 and the control unit 500, all being part of the external device 300. In this case, the acoustic sensing unit 400 may preferably be a microphone enclosed in the housing of the external device.
[0068] Figure 3 A flow chart depicting a third embodiment of a system 100 for measuring hit rate and / or inspiratory airflow, e.g., based on acoustic and / or motion signals caused by a subject's breathing, e.g., in response to electrical neural stimulation, Figure 3 The system 100 is also specified to implement a motion sensing unit 600 for detecting muscle contraction in addition to the acoustic sensing unit 400.
[0069] In order to determine the movement (i.e., contraction) of one or more muscles associated with the subject's breathing pattern, for example in response to an electric field applied by the implant unit 200, the system 100 includes a motion sensing unit 600, which includes at least one inertial measurement unit and / or at least one strain gauge. The inertial measurement unit may include at least one accelerometer and / or at least one gyroscope and / or at least one magnetometer. For example, the degree of protrusion of the subject's tongue can be determined, for example, by detecting movement of muscles associated with the tongue or by detecting movement of the subject's jaw. Automatic adjustment can include the control unit 500 receiving a value indicative of inspiratory airflow from the motion sensing unit 600 and / or the acoustic sensing unit 400, and thereupon adjusting at least one stimulation parameter after a set time delay or more or less immediately (i.e., in real time).
[0070] The invention is not limited to one of the embodiments described herein, but can be modified in many other ways.
[0071] All features and all advantages disclosed by the claims, the description and the drawings, including structural details, spatial arrangements and method steps, may be essential to the invention per se or in any combination with one another.
[0072] Reference numerals list
[0073] 100 Systems
[0074] 200 Implant Units
[0075] 300 External devices
[0076] 400 Acoustic Sensing Units
[0077] 401 Inertial Measurement Unit
[0078] 402 Strain Gauge
[0079] 500 Control Unit
[0080] 600 Motion Sensing Unit
Claims
1. A method for sensing respiration of a subject, the method comprising: - measuring acoustic and / or motor signals caused by the subject's breathing during an electrical nerve stimulation session; - assigning a value indicative of a hit rate and / or an inspiratory airflow to the measured acoustic signal and / or the measured motion signal.
2. The method according to claim 1, characterized in that The method further comprises: - generating a modulation signal, the modulation signal comprising an electrical stimulation pattern; - applying a modulated signal to at least one pair of electrodes associated with an implant unit implanted in a subject; - adjusting at least one parameter of the electrical stimulation pattern in response to a value indicative of the measured hit rate and inspiratory airflow.
3. The method according to claim 1 or 2, characterized in that: The acoustic signal comprises breathing sounds of the subject, and the motor signal comprises movement or contraction of one or more muscles associated with the airway of the subject.
4. A method according to any one of the preceding claims, wherein: The acoustic signal is measured using at least one acoustic sensing unit, wherein the acoustic sensing unit may in particular comprise at least one microphone.
5. The method according to any one of claims 2 to 4, characterized in that Movement or contraction of muscles associated with the airway of the subject includes airway muscle contraction, a change in the position of the subject's tongue, and / or a change in the spatial orientation of the tongue within the subject.
6. The method according to any one of claims 2 to 5, characterized in that Movement of the one or more muscles associated with the airway of the subject is determined using at least one motion sensing unit.
7. The method according to claim 6, characterized in that The at least one motion sensing unit comprises at least one inertial measurement unit and / or at least one strain gauge.
8. The method according to claim 7, characterized in that The inertial measurement unit comprises at least one accelerometer and / or at least one gyroscope and / or at least one magnetometer.
9. The method according to any one of the preceding claims, characterized in that The at least one parameter includes pulse train amplitude, pulse train length, single pulse frequency, single pulse duration, hold duration, pulse train interval, duty cycle, delay time, ramp duration, step-down amplitude, ramp duration at the start of a sequence, and / or confirmation pulse / sequence amplitude.
10. A system for implementing the method according to any one of the preceding claims, the system comprising: - an implant unit configured for implantation proximate any muscle associated with an airway opening of the subject; - an external device configured to communicate with the implanted unit; - At least one acoustic sensing unit and / or at least one motion sensing unit.
11. The system of claim 8, wherein the at least one acoustic sensing unit is part of the external device, and wherein the at least one motion sensing unit is part of the external device or the implanted device.
12. Use of a method according to any one of claims 1 to 9 in the treatment of obstructive sleep apnea.
